New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Jaypirca, Eli Lilly’s treatment for relapsed or refractory mantle cell lymphoma.
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Jaypirca, Eli Lilly’s treatment for relapsed or refractory mantle cell lymphoma.